• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高钾血症患者的住院指征。

Indications for hospitalization of patients with hyperkalemia.

作者信息

Charytan D, Goldfarb D S

机构信息

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Mass, USA.

出版信息

Arch Intern Med. 2000 Jun 12;160(11):1605-11. doi: 10.1001/archinte.160.11.1605.

DOI:10.1001/archinte.160.11.1605
PMID:10847253
Abstract

BACKGROUND

Although the methods for the appropriate management of patients with hyperkalemia are well established, no criteria for hospital admission of patients with this common electrolyte disorder have been promulgated.

OBJECTIVES

To examine the current practices regarding hospitalization of patients with hyperkalemia and to consider appropriate criteria for admission.

PATIENTS AND METHODS

We evaluated a consecutive series of patients hospitalized for hyperkalemia and excluded patients who developed hyperkalemia after admission. For comparison, we selected a series of patients with a similar degree of hyperkalemia who were treated as outpatients. Hyperkalemia was classified as minimal, moderate, or severe. The causes of hyperkalemia were identified, and the therapeutic maneuvers used were ascertained. Although the study did not have the power to determine the relative safety of the 2 therapeutic approaches, we compared the outcomes of the 2 groups of patients.

RESULTS

The inpatient group consisted of 11 patients who were admitted for the treatment of hyperkalemia, and we identified 12 patients who received outpatient therapy for hyperkalemia. The patients in the 2 treatment groups were similar with respect to age and the values of serum urea nitrogen, creatinine, and potassium prior to the identification of hyperkalemia. The mean +/-SD potassium concentrations at baseline were 5.4+/-0.7 mmol/L in the inpatients and 5.5+/-0.5 mmol/L in the outpatients. The mean +/-SD potassium concentration in the inpatients was 6.7+/-0.8 mmol/L at the time of hospital admission, compared with 6.7+/-0.5 mmol/L in the outpatients at the time that hyperkalemia occurred. Similar proportions of both groups (6 of 11 inpatients and 7 of 12 outpatients) had moderate or severe hyperkalemia.

CONCLUSIONS

Patients admitted to the hospital were clinically indistinguishable from patients treated as outpatients. The justification for the decision to admit patients to the hospital or to treat them as outpatients was often not evident. We suggest criteria for hospitalization, which include severe hyperkalemia (> or =8.0 mmol/L, with changes other than peaked T waves on the electrocardiogram), acute worsening of renal function, and supervening medical problems.

摘要

背景

尽管高钾血症患者的恰当管理方法已确立,但针对这种常见电解质紊乱患者的住院标准尚未公布。

目的

探讨高钾血症患者住院治疗的当前做法,并考虑合适的入院标准。

患者与方法

我们评估了一系列因高钾血症住院的连续患者,并排除入院后发生高钾血症的患者。为作比较,我们选取了一系列血钾升高程度相似的门诊治疗患者。高钾血症分为轻度、中度或重度。确定高钾血症的病因,并确定所采用的治疗手段。尽管该研究无力确定两种治疗方法的相对安全性,但我们比较了两组患者的结局。

结果

住院组包括11例因高钾血症入院治疗的患者,我们确定了12例接受高钾血症门诊治疗的患者。两个治疗组的患者在年龄以及高钾血症确诊前的血清尿素氮、肌酐和钾值方面相似。住院患者基线时的平均±标准差钾浓度为5.4±0.7 mmol/L,门诊患者为5.5±0.5 mmol/L。住院患者入院时的平均±标准差钾浓度为6.7±0.8 mmol/L,而门诊患者高钾血症发生时为6.7±0.5 mmol/L。两组中相似比例的患者(11例住院患者中的6例和12例门诊患者中的7例)患有中度或重度高钾血症。

结论

入院患者与门诊治疗患者在临床上并无差异。决定患者入院或门诊治疗的理由往往并不明确。我们建议了住院标准,包括严重高钾血症(≥8.0 mmol/L,心电图除T波高尖外还有其他变化)、肾功能急性恶化以及并发的医疗问题。

相似文献

1
Indications for hospitalization of patients with hyperkalemia.高钾血症患者的住院指征。
Arch Intern Med. 2000 Jun 12;160(11):1605-11. doi: 10.1001/archinte.160.11.1605.
2
Trimethoprim-sulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem?门诊患者的甲氧苄啶-磺胺甲恶唑治疗:高钾血症是一个严重问题吗?
Am J Nephrol. 1999;19(3):389-94. doi: 10.1159/000013483.
3
[Influence of hyperkalemia on clinical decision making].
Rinsho Byori. 1996 Nov;44(11):1087-92.
4
Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole.接受甲氧苄啶-磺胺甲恶唑治疗的住院患者中的高钾血症。
Ann Intern Med. 1996 Feb 1;124(3):316-20. doi: 10.7326/0003-4819-124-3-199602010-00006.
5
Effects of presentation and electrocardiogram on time to treatment of hyperkalemia.临床表现和心电图对高钾血症治疗时间的影响。
Acad Emerg Med. 2008 Mar;15(3):239-49. doi: 10.1111/j.1553-2712.2008.00058.x.
6
Severe hyperkalemia requiring hospitalization: predictors of mortality.需要住院治疗的严重高钾血症:死亡率的预测因素。
Crit Care. 2012 Nov 21;16(6):R225. doi: 10.1186/cc11872.
7
The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia.苯乙烯磺酸纳在高钾血症住院患者管理中的应用。
J Hosp Med. 2011 Mar;6(3):136-40. doi: 10.1002/jhm.834.
8
Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).依普利酮在高血钾风险和/或肾功能恶化患者中的安全性和疗效:EMPHASIS-HF 研究亚组分析(心力衰竭患者依普利酮住院和生存研究)。
J Am Coll Cardiol. 2013 Oct 22;62(17):1585-93. doi: 10.1016/j.jacc.2013.04.086. Epub 2013 Jun 27.
9
Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines.住院患者高钾血症:病因、治疗的充分性以及为提高医生对已发表治疗指南的依从性所做尝试的结果
Arch Intern Med. 1998 Apr 27;158(8):917-24. doi: 10.1001/archinte.158.8.917.
10
Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals.危及生命的药物相关性高钾血症:来自实验室信号的回顾性研究。
Pharmacoepidemiol Drug Saf. 2011 Jul;20(7):747-53. doi: 10.1002/pds.2128. Epub 2011 Mar 16.

引用本文的文献

1
Inpatient management and post-discharge outcomes of hyperkalemia.高钾血症的住院管理和出院后结局。
Hosp Pract (1995). 2021 Oct;49(4):273-279. doi: 10.1080/21548331.2021.1925554. Epub 2021 May 26.
2
Serum Potassium Levels at Hospital Discharge and One-Year Mortality among Hospitalized Patients.血清钾水平与住院患者出院后一年的死亡率。
Medicina (Kaunas). 2020 May 14;56(5):236. doi: 10.3390/medicina56050236.
3
Ghanaians Might Be at Risk of Excess Dietary Intake of Potassium Based on Food Supply Data.根据食物供应数据,加纳人可能面临钾摄入过量的风险。
J Nutr Metab. 2018 Oct 17;2018:5989307. doi: 10.1155/2018/5989307. eCollection 2018.
4
Extended release potassium salts overdose and endoscopic removal of a pharmacobezoar: A case report.缓释钾盐过量与药物性胃石的内镜下取出:一例报告
Toxicol Rep. 2014 May 22;1:209-213. doi: 10.1016/j.toxrep.2014.04.002. eCollection 2014.
5
Periodic paralysis: An unusual presentation of drug-induced hyperkalemia.周期性麻痹:药物性高钾血症的一种不寻常表现。
J Pharmacol Pharmacother. 2014 Jan;5(1):63-6. doi: 10.4103/0976-500X.124429.
6
A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers.血管紧张素转换酶抑制剂与血管紧张素受体阻滞剂致高钾血症发生率的对比研究。
Ther Clin Risk Manag. 2009 Jun;5(3):547-52. doi: 10.2147/tcrm.s5176. Epub 2009 Jul 12.
7
The risks and benefits of aldosterone antagonists.醛固酮拮抗剂的风险与益处。
Curr Heart Fail Rep. 2005 Aug;2(2):65-71. doi: 10.1007/s11897-005-0011-5.
8
Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis.盐皮质激素阻断剂的药代动力学和药效学及其对钾稳态的影响。
Heart Fail Rev. 2005 Jan;10(1):23-9. doi: 10.1007/s10741-005-2345-1.